AKT1 and hepatocellular carcinoma: Given increased PCAF expression could inhibit AKT signaling in HCC cells [26, 27], we further scrutinized the results of KEGG analysis with the transcriptome profiles of HCC cells (Fig. 3A), in which pathways in cancer, especially the PI3K-Akt signaling pathway, were significantly hyperactivated.